36 completed, 5 unknown, 3 terminated, 2 recruiting. 48 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 48 | Completed 36, Unknown 5, Terminated 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 3, Unknown 3, Not yet recruiting 1 |
Follow Calcium: new trials by email Literature Review of Calcium trials Research Report on Calcium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta Vitamin D, Calcium - Osteogenesis Imperfecta | Phase 3 | Recruiting | Amgen | 71 | 2026-03-18 | 2026-06-22 |
| Calcium Administration in Life-saving Management During Massive Hemorrhage calcium gluconate, Control: Placebo - Massive Hemorrhage, Trauma | Phase 2 / Phase 3 | Not yet recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 81 | 2025-05-01 | 2025-02-11 |
| Empiric Calcium in Massive Transfusion Calcium Gluconate - Hemorrhage, Trauma | Phase 3 | Withdrawn | University of California, Irvine | 2025-01-01 | 2026-03-30 | |
| Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea Next Generation ORS (oral rehydration solution) (including placebo, Current standard control ORS (oral rehydration solution) - Diarrhea, Cholera | Phase 2 / Phase 3 | Completed | University of Florida | 396 | 2023-08-21 | 2026-04-14 |
| Vitamin D and Calcium Supplementation in Breast Cancer Letrozole 2.5mg, Letrozole + vitamin D3 and calcium - Breast Cancer | Phase 2 / Phase 3 | Unknown | Tanta University | 40 | 2022-11-01 | 2023-12-01 |
| A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. MB09 (denosumab biosimilar), EU-Prolia, Elemental Calcium - Postmenopausal Women With Osteoporosis | Phase 3 | Completed | mAbxience Research S.L. | 558 | 2022-03-16 | 2025-03-21 |
| A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia Calcium, hydrolysed divinylbenzene-Me 2-fluoro-2-propenoate-1, 7-octadiene polymer sorbitol complexes, Placebo - Hyperkalemia | Phase 3 | Completed | Zeria Pharmaceutical | 85 | 2021-08-03 | 2023-04-20 |
| Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence Acamprosate Calcium, Calcium Carbonate, Placebo - Alcoholism | Phase 3 | Completed | Technische Universität Dresden | 82 | 2020-08-05 | 2024-05-29 |
| Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy Daily 500 mg elemental calcium as calcium carbonate, Daily1500 mg elemental calcium as calcium carbonate - Pregnancy Related | Phase 3 | Completed | Harvard School of Public Health (HSPH) | 22000 | 2018-11-30 | 2024-12-24 |
| Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome Vitamin D with calcium and clomiphene citrate, Placebo Oral Tablet with calcium and clomiphene citrate - Ovulation Induction | Phase 3 | Unknown | Ain Shams University | 186 | 2017-07-01 | 2018-01-11 |
| Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women Denosumab, calcium, vitamin D - Osteoporosis | Phase 3 | Unknown | AryoGen Pharmed Co. | 190 | 2017-04-29 | 2020-07-10 |
| Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis Genistein aglycone, Alendronate Oral Tablet, Calcium + vitamin D3 tablet - Osteoporosis, Steroid Induced | Phase 2 / Phase 3 | Unknown | University of Messina | 200 | 2017-01-19 | 2017-03-03 |
| Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents High dose vitamin D and calcium, Normal dose vitamin D and calcium - Adverse Bone Health, HIV Infection | Phase 3 | Completed | Chiang Mai University | 200 | 2015-04-01 | 2019-08-08 |
| Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis orphenadrine, Placebo - Liver Cirrhosis, Muscle Cramps | Phase 3 | Recruiting | Sherief Abd-Elsalam | 100 | 2015-01-01 | 2019-06-07 |
| Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention Oral Cabergoline, Calcium Gluconate - Ovarian Hyperstimulation | Phase 3 | Completed | Benha University | 230 | 2014-10-01 | 2018-03-29 |
| GAit, MEmory, Dietary and Vitamin D Yogurt supplemented with vitamin D and calcium, Yogurt not supplemented with vitamin D and calcium - Memory Complaint Without Cognitive Decline | Phase 2 / Phase 3 | Completed | University Hospital, Angers | 40 | 2014-09-01 | 2016-09-22 |
| Denosumab China Phase III Study Denosumab, Placebo, Elemental Calcium - Osteoporosis, Postmenopausal | Phase 3 | Completed | GlaxoSmithKline | 486 | 2014-01-01 | 2016-10-31 |
| Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer folic acid, folic acid calcium vitamin D3, calcium - Colorectal Neoplasms | Phase 2 / Phase 3 | Unknown | Shanghai Jiao Tong University School of Medicine | 2400 | 2013-01-01 | 2014-02-20 |
| Calcium for Prevention of Ovarian Hyperstimulation Syndrome calcium, 0.9 % saline - Ovarian Hyperstimulation Syndrome | Phase 3 | Completed | Cairo University | 200 | 2011-10-01 | 2014-07-09 |
| Zometa Study in Pediatric Acute Lymphoblastic Leukemia zolendronic acid, calcium & vitamin D - Osteoporosis | Phase 3 | Completed | Children's Cancer Hospital Egypt 57357 | 95 | 2011-10-01 | 2018-04-17 |
Showing 20 of 48. Sign in to see all of them.
Osteoporosis (12) · Breast Neoplasms (5) · Bone Diseases, Metabolic (4) · Osteoporosis, Postmenopausal (3) · Cardiovascular Diseases (2) · Colorectal Neoplasms (2) · Heart Diseases (2) · Hypocalcemia (2) · Osteitis Deformans (2) · Pain (2) · Prostatic Neoplasms (2) · Wounds and Injuries (2) · Acquired Immunodeficiency Syndrome (1) · Alcoholism (1) · Arthritis, Juvenile (1)
Novartis Pharmaceuticals (3) · Creighton University (2) · Novartis (2) · Radiation Therapy Oncology Group (2) · Ain Shams University (1) · Amgen (1) · AryoGen Pharmed Co. (1) · Benha University (1) · Cairo University (1) · Chadi A. Calarge (1) · Chiang Mai University (1) · Children's Cancer Hospital Egypt 57357 (1) · Chinese University of Hong Kong (1) · Chugai Pharmaceutical (1) · Copenhagen University Hospital, Rigshospitalet (1)
United States (13) · Germany (7) · Canada (6) · Egypt (6) · France (4) · Australia (3) · Belgium (3) · China (3) · Japan (3) · Spain (3) · United Kingdom (3) · Denmark (2) · Hungary (2) · India (2) · Italy (2)
Asem A Elfert, Professor (1) · Ashraf N Elmantwe, MD (1) · Baha Sibai (1) · Bess Dawson-Hughes, MD (1) · Chadi Calarge, M.D. (1) · Charles Loprinzi (1) · Colleen A. Lawton, MD (1) · Cynthia Morris (1) · Dr Manjari Tripathy, DM (1) · Dr Manju Vatsa (1) · Dr Nandita Dupta, PhD (1) · Dr Ravinder Goswami, MD, DM (1)
PMID 10511362, PMID 11395985, PMID 16467232, PMID 16467233, PMID 16467234, PMID 16481635, PMID 16481636, PMID 16580279, PMID 16609086, PMID 16880313, PMID 16946216, PMID 17277040, PMID 17341712, PMID 17405972, PMID 17502530, PMID 17556697, PMID 17582069, PMID 17925539, PMID 18235052, PMID 18299491, PMID 18319414, PMID 18489937, PMID 18502208, PMID 18663162, PMID 18821668, PMID 18822620, PMID 19001202, PMID 19005970, PMID 19193613, PMID 19204221, PMID 19221190, PMID 19402886, PMID 19403636, PMID 19423530, PMID 19474140, PMID 19767090, PMID 19822825, PMID 19861516, PMID 20056625, PMID 20157135, PMID 20160160, PMID 20181812, PMID 20354566, PMID 20433539, PMID 20667078, PMID 20833684, PMID 20884191, PMID 20937929, PMID 20959578, PMID 20980487
2009 (1), 2023 (1), K23MH085005 (1), P30CA015083 (1), R21AI169282 (1)